AngioDynamics(ANGO)

产业链观察04-04 20:29

#药闻简讯# 美国FDA已经批准了$AngioDynamics(ANGO)$ 用于治疗肺栓塞（PE）的AlphaVac F1885系统，增强了其在PE等关键医疗场景中的实用性。查看全文

当期报告

AngioDynamics(ANGO)04-02 05:35

$AngioDynamics(ANGO)$ 8-K Current report, item 1.01 Accession Number: 0001140361-24-016977  Act: 34  Size: 159 KB 网页链接查看全文

持股变动声明

AngioDynamics(ANGO)04-09 04:35

$AngioDynamics(ANGO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-24-018620  Size: 4 KB 网页链接查看全文

季度财报

AngioDynamics(ANGO)04-10 05:15

$AngioDynamics(ANGO)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001628280-24-015487  Act: 34  Size: 7 MB 网页链接查看全文

持股变动声明

AngioDynamics(ANGO)03-05 09:55

$AngioDynamics(ANGO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001140361-24-011190  Size: 4 KB 网页链接查看全文

当期报告

AngioDynamics(ANGO)04-04 19:35

$AngioDynamics(ANGO)$ 8-K Current report, items 2.02, 7.01, and 9.01 Accession Number: 0001140361-24-017807  Act: 34  Size: 5 MB 网页链接查看全文

产业链观察04-04 20:29

#药闻简讯# 美国FDA已经批准了$AngioDynamics(ANGO)$ 用于治疗肺栓塞（PE）的AlphaVac F1885系统，增强了其在PE等关键医疗场景中的实用性。查看全文

一年交易一次2019-01-04 09:48

$盎格鲁力学(ANGO)$
$卡尔梅尔食品(CALM)$
$Lamb Weston控股(LW)$
RPM国际(RPM)
等四只股票盘前要发财报。#今日财报预告#查看全文

用户18509225712018-07-11 12:20

$盎格鲁力学(ANGO)$ 计划于北京时间 2018-07-11 20:00（2018/07/11 08:00 EDT）举行 2018 财年 Q4 财报电话会议。
AngioDynamics, Inc.主要是设计、制造、销售各类医疗外科和诊断设备，设备用于专业医护人员在血管通路、血管周围疾病治疗和肿瘤手术设置方面的应用。公司1988年开始运营。公司...查看全文

$AngioDynamics(ANGO)$ 8-K - Current report Filed: 2016-11-18 AccNo: 0000914121-16-001680 Size: 247 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接

$AngioDynamics(ANGO)$ 424B7 - Prospectus [Rule 424(b)(7)] Filed: 2016-11-16 AccNo: 0001193125-16-769814 Size: 255 KB 网页链接

$AngioDynamics(ANGO)$ 424B7 - Prospectus [Rule 424(b)(7)] Filed: 2016-11-14 AccNo: 0001193125-16-767929 Size: 255 KB 网页链接

$AngioDynamics(ANGO)$ 8-K - Current report Filed: 2016-11-10 AccNo: 0000914121-16-001647 Size: 1 MBItem 1.01: Entry into a Material Definitive AgreementItem 1.02: Termination of a Material Definitive AgreementItem 2.03: Creation of a Direct Financial Obligation or an Obligati...

$AngioDynamics(ANGO)$ 8-K - Current report Filed: 2016-10-28 AccNo: 0000914121-16-001612 Size: 27 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接

$AngioDynamics(ANGO)$ 8-K - Current report Filed: 2016-10-07 AccNo: 0000914121-16-001523 Size: 263 KBItem 4.01: Changes in Registrant's Certifying AccountantItem 9.01: Financial Statements and Exhibits 网页链接

$AngioDynamics(ANGO)$ 8-K - Current report Filed: 2016-10-05 AccNo: 0000914121-16-001512 Size: 449 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接

$AngioDynamics(ANGO)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2016-10-05 AccNo: 0001275187-16-000037 Size: 5 MB 网页链接

$AngioDynamics(ANGO)$ 美东时间 2016-10-05 09:00 Before Open:ANGIODYNAMICS Earning Release . Wall St EPS Est ($):0.13. 网页链接

$AngioDynamics(ANGO)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2016-09-15 AccNo: 0001193125-16-711008 Size: 72 KB 网页链接